Inventaire - your friends and communities are your best library

Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis

author

Shirin Farjadian

Mohammad Reza Panjehshahin

published in: Iranian journal of pharmaceutical research

date of publication: 2014-01-01

main subject: multiple sclerosis, experimental autoimmune encephalomyelitis

Cites articles 44

Date

Title

Authors

2012-01-01

Effect of honey bee venom on lewis rats with experimental allergic encephalomyelitis, a model for multiple sclerosis
2012-07-18

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

Mohammad Ehsanul Karim, Helen Tremlett, Elaine Kingwell, Mia L van der Kop, Afsaneh Shirani, Yinshan Zhao, Charity Evans, Joel Oger, Paul Gustafson
2012-07-01

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease

Jack T Rogers
2012-09-01

Neurogenesis enhancer RO 25-6981 facilitates repeated spatial learning in adult rats.
2012-07-16

Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-β oligomers

Catarina R. Oliveira, William L. Klein
2011-10-05

Pharmacologic treatment for memory disorder in multiple sclerosis
2011-09-01

Targeting progressive neuroaxonal injury: lessons from multiple sclerosis

Amit Bar-or, Anthony Traboulsee, V. Wee Yong
2011-05-01

Progressive multiple sclerosis: characteristics and management
2011-12-17

GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine
2011-02-12

Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.

Jan M. Deussing, Christopher G. Parsons
2011-12-16

Memantine for axonal loss of optic neuritis

Masoud Aghsaei Fard
2010-05-18

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial
2008-11-01

Neurodegeneration and neuroprotective agents in multiple sclerosis
2008-08-05

Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity
2008-08-07

Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance
2007-07-25

MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum
2007-08-01

Comparative study of preventive and therapeutic effects of IEM-1966 and memantine in rats with experimental allergic encephalomyelitis
2007-03-01

NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo.

Yu Tian Wang, Tak Pan Wong, Michelle Aarts, Ted Weita Lai, Dong Chuan Wu
2006-12-28

Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis
2006-09-24

Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-D-aspartate (NMDA) receptor activation
2006

Glutamate receptors in neuroinflammatory demyelinating disease,Glutamate Receptors in Neuroinflammatory Demyelinating Disease
2006-03-01

Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors

Michel Baudry
2005-08-01

Effective combination of minocycline and interferon-beta in a model of multiple sclerosis
2004-02-01

The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies
2003-10-01

Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity
2002-07-01

Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine
2000-09-28

Multiple sclerosis
2000-07-01

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

Tommy Olsson
2000

Molecular mechanisms of calcium-dependent excitotoxicity
2000-01-01

Glutamate excitotoxicity in a model of multiple sclerosis
2000-01-01

Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?
1998-12-01

Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity

Article - wd:Q34146191

Welcome to Inventaire

the library of your friends and communities

learn more